Alzheimer’s drugmakers seek accelerated FDA review despite limited government coverage by Editor | Apr 11, 2022 | Government, Regulatory & Policy News, Hospitals, LATEST NEWS, WORLD NEWS | 0 USA – Eisai Co Ltd and Eli Lilly and Co have said that they will continue to seek accelerated U.S.... Read More